These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16469608)

  • 1. Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.
    St Sauver JL; Jacobson DJ; Girman CJ; Lieber MM; McGree ME; Jacobsen SJ
    J Urol; 2006 Mar; 175(3 Pt 1):1018-22; discussion 1022. PubMed ID: 16469608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between longitudinal changes in transitional zone volume and measures of benign prostatic hyperplasia in a population-based cohort.
    St Sauver JL; Jacobson DJ; Girman CJ; McGree ME; Lieber MM; Jacobsen SJ
    Eur Urol; 2006 Jul; 50(1):105-11. PubMed ID: 16466847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.
    St Sauver JL; Jacobson DJ; McGree ME; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Oct; 164(8):760-8. PubMed ID: 16905643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes in peak urinary flow rates in a community based cohort.
    Roberts RO; Jacobsen SJ; Jacobson DJ; Rhodes T; Girman CJ; Lieber MM
    J Urol; 2000 Jan; 163(1):107-13. PubMed ID: 10604326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
    Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
    J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
    Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
    J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.
    Burke JP; Jacobson DJ; McGree ME; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    Urology; 2006 Jan; 67(1):22-5. PubMed ID: 16413325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?
    Carter HB; Landis P; Wright EJ; Parsons JK; Metter EJ
    J Urol; 2005 Jun; 173(6):2040-3. PubMed ID: 15879821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the proscar long-term efficacy and safety study.
    Paick SH; Meehan A; Lee M; Penson DF; Wessells H
    J Urol; 2005 Mar; 173(3):903-7. PubMed ID: 15711315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
    Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
    Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride.
    Andriole GL; Marberger M; Roehrborn CG
    J Urol; 2006 May; 175(5):1657-62. PubMed ID: 16600723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study.
    Bohnen AM; Groeneveld FP; Bosch JL
    Eur Urol; 2007 Jun; 51(6):1645-52; discussion 1652-3. PubMed ID: 17320271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of benign prostatic hyperplasia disease.
    Marks LS; Roehrborn CG; Andriole GL
    J Urol; 2006 Oct; 176(4 Pt 1):1299-306. PubMed ID: 16952616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of at-risk patients: baseline variables.
    Roehrborn CG
    BJU Int; 2006 Apr; 97 Suppl 2():7-11; discussion 21-2. PubMed ID: 16507046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia.
    Lee SE; Chung JS; Han BK; Moon KH; Hwang SI; Lee HJ; Choe G; Hong SK
    Urology; 2008 Mar; 71(3):395-8. PubMed ID: 18342171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.